In this issue:
Oral icotrokinra for plaque psoriasis
Benefits of interdisciplinary psoriasis care
Coach-supported cognitive behavioural therapy app
Apremilast in paediatric patients with moderate-to-severe plaque psoriasis
KLRB1 and IL-12RB1 predict relapse after IL-17 blockade
Biologics in psoriasis patients with malignancy
Dermoscopic differentiation of mycosis fungoides, atopic dermatitis, and psoriasis
Subclinical atherosclerosis in psoriasis patients
Biologics for treatment of paediatric plaque psoriasis
Systemic inflammatory biomarkers mediating psoriasis and depression
Download PDF